Today: 4 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Warby Parker (WRBY) Soars on Google AI Glasses News: Is the Stock a Buy After December 2025’s Rally?

Warby Parker (WRBY) Soars on Google AI Glasses News: Is the Stock a Buy After December 2025’s Rally?

Warby Parker shares jumped over 13% to around $22 after Google confirmed their co-developed AI smart glasses will launch in 2026. The announcement, made at The Android Show, marks the first public timeline for the product. Google has committed up to $150 million to the partnership. Shares of rival EssilorLuxottica fell 4% as investors reacted to the news.
9 December 2025
···
(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

(OCUL) Stock Soars on Accelerated Wet AMD NDA – Price, Forecast & Risk Analysis as of December 9, 2025

Ocular Therapeutix shares surged 28.1% to $16.11 on December 8, hitting a new 52-week high after the company announced plans to file an accelerated NDA for its retina drug AXPAXLI in wet AMD, based on a single Phase 3 trial. Trading volume spiked, and year-to-date gains reached about 44%. The company aims to submit the NDA after year-one SOL-1 trial data in Q1 2026.
9 December 2025
Therapeutics (KYMR) Stock Rockets on KT‑621 Eczema Breakthrough, Then Pauses After $500M Share Offering – 9 December 2025 Update

Therapeutics (KYMR) Stock Rockets on KT‑621 Eczema Breakthrough, Then Pauses After $500M Share Offering – 9 December 2025 Update

Kymera Therapeutics shares jumped 41.6% to close at $94.30 on December 8 after its oral STAT6 degrader KT-621 showed dupilumab-like efficacy and clean safety in a small Phase 1b eczema trial. The company announced a $500 million stock offering the same day, sending shares lower in after-hours trading. Analyst price targets rose, some reaching $138.
9 December 2025
····
Structure Therapeutics (GPCR) Stock Explodes on Obesity Pill Breakthrough: Latest News, Analyst Targets and 2026–2035 Outlook

Structure Therapeutics (GPCR) Stock Explodes on Obesity Pill Breakthrough: Latest News, Analyst Targets and 2026–2035 Outlook

Structure Therapeutics shares doubled to $69.98 mid-day December 9 after reporting strong Phase 2b data for its oral obesity drug, aleniglipron. The 120 mg dose showed 11.3% placebo-adjusted weight loss over 36 weeks; higher doses reached 15.3%. No drug-induced liver injury or QTc prolongation was reported. Market cap stands near $4 billion, with the stock trading close to its 52-week high.
9 December 2025
··
B2Gold Corp (BTG) Stock Update for December 9, 2025: Goose Mine Milestone, Q3 Beat and Analyst Price Targets

B2Gold Corp (BTG) Stock Update for December 9, 2025: Goose Mine Milestone, Q3 Beat and Analyst Price Targets

B2Gold Corp reported Q3 2025 gold revenue of $782.9 million, up 75% year-over-year, after achieving commercial production at its Goose Mine in Nunavut. Shares traded near $4.48 midday Dec. 9, valuing the company at $6.1 billion. Net income reached $19–23 million, reversing a loss last year. Gold output totaled 254,369 ounces, with costs and production beating targets.
9 December 2025
····
Hecla Mining (HL) Stock on December 9, 2025: S&P MidCap 400 Inclusion, Record Earnings and High‑Risk Silver Upside

Hecla Mining (HL) Stock on December 9, 2025: S&P MidCap 400 Inclusion, Record Earnings and High‑Risk Silver Upside

Hecla Mining shares fell about 6% Monday to $15.85, extending a sharp pullback from last week’s record high of $18.12. The stock remains up nearly 300% from its 52-week low and is set to join the S&P MidCap 400 index on December 22. Market cap stands near $11.5 billion. Volatility remains high following a historic silver rally and record earnings.
9 December 2025
·
Alibaba (BABA) Stock on December 9, 2025: Earnings Shock, AI Super‑App Bets and What Wall Street Expects Next

Alibaba (BABA) Stock on December 9, 2025: Earnings Shock, AI Super‑App Bets and What Wall Street Expects Next

Alibaba shares traded near $158 in New York and HK$153 in Hong Kong midday December 9, 2025, both slightly lower. The company reported September quarter operating income down 85% year-over-year to RMB 5.4 billion, with non-GAAP net income falling 72%. Revenue rose 5% to RMB 247.8 billion. Analysts remain split, with technical models rating the stock from “Sell candidate” to “40% Buy.”
9 December 2025
····
Playboy, Inc. (PLBY) Stock in 2025: First Profit, Licensing Pivot and High‑Risk Upside – What Investors Need to Know Now

Playboy, Inc. (PLBY) Stock in 2025: First Profit, Licensing Pivot and High‑Risk Upside – What Investors Need to Know Now

Playboy, Inc. posted its first quarterly profit since going public and won an $81 million arbitration award, sending shares up over 60% in the past year. The company now relies on a 15-year, $300 million licensing deal with Byborg Enterprises and relaunched its print magazine in 2025. Despite gains, Playboy remains heavily leveraged with negative free cash flow. Market cap stands at about $230 million.
9 December 2025
·
Magnum Ice Cream Company N.V. (MICC) Stock: Fresh Analyst Ratings, Outlook and Risks After the Unilever Demerger – 9 December 2025

Magnum Ice Cream Company N.V. (MICC) Stock: Fresh Analyst Ratings, Outlook and Risks After the Unilever Demerger – 9 December 2025

Magnum Ice Cream Company (MICC), newly spun out from Unilever, began trading last week in Amsterdam, London, and New York with a reference price of €12.80 per share and a €7.8–7.9 billion valuation. JPMorgan rated the stock Neutral with a €14 target, while UBS and Morningstar were more bullish. Regulatory filings showed top executives buying shares. Unilever retains a 19.9% stake post-demerger.
9 December 2025
·
Alphabet (GOOG, GOOGL) Stock on December 9, 2025: EU AI Probe, Gemini 3 Momentum and Bold 2026 Price Targets

Alphabet (GOOG, GOOGL) Stock on December 9, 2025: EU AI Probe, Gemini 3 Momentum and Bold 2026 Price Targets

Alphabet’s Q3 2025 revenue hit $102.3 billion, its first quarter above $100 billion, with net income up 33% to $35 billion. As of midday December 9, Alphabet shares traded near $314, giving it a $3.8 trillion market cap, third worldwide. The stock is up about 67% year to date, outpacing peers. Regulatory scrutiny continues, including a €3.5 billion EU antitrust fine in Q3.
9 December 2025
···
Eaton Stock (ETN) on December 9, 2025: Wolfe Upgrade, AI Data Center Bets and What It Means for Investors

Eaton Stock (ETN) on December 9, 2025: Wolfe Upgrade, AI Data Center Bets and What It Means for Investors

Eaton shares closed at $343.39 on December 8, up 1.7% after Wolfe Research upgraded the stock to Outperform with a $413 target. The move follows a 13% drop from summer highs and underperformance versus the S&P 500. Eaton has expanded in AI data centers and electrification, posting record earnings and a $9.5 billion liquid-cooling acquisition. The stock trades at about 34 times trailing earnings.
9 December 2025
···
iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)

iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)

iBio, Inc. shares surged 39% Monday to close at $1.67 on heavy volume, lifting its market value to about $37.5 million. The stock traded higher pre-market Tuesday, with quotes between $1.76 and $1.81. The company reported $49.6 million in cash after a recent offering and says this will fund operations into late 2027. Lead obesity drug candidate IBIO-610 has shown fat-selective weight loss in animal studies.
9 December 2025
·
AlphaTime Acquisition Corp (ATMC) Skyrockets After HCYC Merger Vote: Latest News, Deal Terms and 2026 Outlook

AlphaTime Acquisition Corp (ATMC) Skyrockets After HCYC Merger Vote: Latest News, Deal Terms and 2026 Outlook

AlphaTime Acquisition Corp (NASDAQ: ATMC) surged over 600% in pre-market trading on December 9, 2025, hitting $104.70 after shareholders approved a merger with Hong Kong insurance broker HCYC. The spike pushed its implied market cap to about $267 million, far above the $75 million equity value set in the merger. ATMC had closed at $15.60 the previous day. The company has no significant operations of its own.
9 December 2025
··
AeroVironment (AVAV) Stock: $874M Army Deal, Q2 Earnings, and 2026 Price Targets on December 9, 2025

AeroVironment (AVAV) Stock: $874M Army Deal, Q2 Earnings, and 2026 Price Targets on December 9, 2025

AeroVironment shares traded near $282 on December 9, 2025, up over 80% in a year but still 32% below the $417.86 high. The company secured an $874 million U.S. Army contract for drone and counter-drone systems. Market cap stands at about $14 billion, with trailing 12-month revenue of $1.09 billion and a net loss of $45 million. Forward P/E is around 66.
9 December 2025
··
Coca-Cola (KO) Stock on December 9, 2025: Price, Fresh News, Analyst Targets and Long‑Term Forecast

Coca-Cola (KO) Stock on December 9, 2025: Price, Fresh News, Analyst Targets and Long‑Term Forecast

Coca-Cola shares closed at $70.25 on December 8, 2025, near the midpoint of their 52-week range. Institutional ownership remains above 70%, with Axa S.A. increasing its stake by 22.7% and Fayez Sarofim & Co. trimming holdings by 4.2%. The stock faces a new legal challenge from San Francisco over ultra-processed foods. KO trades at a trailing P/E of about 23 and a market cap near $302 billion.
9 December 2025
·
Berkshire Hathaway Stock (BRK.A, BRK.B) Today: Leadership Shake-Up, Q3 Earnings, and 2026 Forecasts – December 9, 2025

Berkshire Hathaway Stock (BRK.A, BRK.B) Today: Leadership Shake-Up, Q3 Earnings, and 2026 Forecasts – December 9, 2025

Berkshire Hathaway Class B shares traded around $497, down 1–1.5% midday on Dec. 9, as the company prepares for Warren Buffett to step down as CEO at year-end, with Greg Abel set to take over Jan. 1. The firm is also managing the exit of key executives and reported strong Q3 earnings driven by insurance profits. Market cap stands near $1.07 trillion. Analyst views on the stock remain mixed.
9 December 2025
····
Paranovus Entertainment (PAVS) Stock Rockets in Pre‑Market on CEO Report After 18,037% Revenue Surge – December 9, 2025 Update

Paranovus Entertainment (PAVS) Stock Rockets in Pre‑Market on CEO Report After 18,037% Revenue Surge – December 9, 2025 Update

Paranovus Entertainment shares surged as much as 54.8% to $1.02 in pre-market trading Tuesday after a report that Rich Wheeless was named CEO. The move followed interim results showing 18,037% year-over-year revenue growth and a swing to profit. Shares closed Monday at $0.0489, still down over 90% in two weeks. Most data providers had not confirmed the pre-market spike by early Tuesday.
9 December 2025
·
Rheinmetall AG Stock on December 9, 2025: German Mega‑Orders, Record Backlog and What Analysts Expect Next

Rheinmetall AG Stock on December 9, 2025: German Mega‑Orders, Record Backlog and What Analysts Expect Next

Rheinmetall shares rose up to 4% on December 9 as Germany’s Bundestag prepared to approve €52 billion in new defense procurement, including major contracts for Puma vehicles and ammunition. The stock traded near €1,645, up 10% over five sessions and 160% year-to-date. Analysts estimate the Puma deal alone could bring Rheinmetall €2 billion. A separate tank ammunition order worth several hundred million euros was announced December 8.
9 December 2025
··
1 … 498 499 500 501 502 … 584
Go toTop